Physician profile
Christopher Cantu
NPI 1124685193
$892.22
in general payments reported to CMS, 2019-2025
7 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.76 · 2023: $163 · 2024: $556 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $308.79 | 2024-2025 | Kisunla, Amyvid |
| Tg Therapeutics, INC. | $267.31 | 2024 | |
| Biogen, INC. | $127.19 | 2023 | Tysabri, Vumerity |
| Livanova USA, INC. | $123.81 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2021 | |
| Ucb, INC. | $19.54 | 2023 | Briviact |
| Novartis Pharmaceuticals Corporation | $15.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cantu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.